drugset / Trial / NCT04689191
A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is a randomized, double-blinded, and controlled phase III clinical trial of the Group A and C meningococcal polysaccharide vaccine to evaluate the safety and immunogenicity of the vaccine in healthy infants aged 2-6 years.
Timeline
- Start
- 2020-09-15
- Primary completion
- 2021-05
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Control Group A and C meningococcal polysaccharide vaccine | Vaccine | — | — |
| Subject | Experimental Group A and C meningococcal polysaccharide vaccine | Vaccine | — | — |